{"id":292393,"date":"2026-10-07T13:28:39","date_gmt":"2026-10-07T07:58:39","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=292393"},"modified":"2026-10-07T13:28:39","modified_gmt":"2026-10-07T07:58:39","slug":"hospital-and-life-science-stocks-strong-roadmap","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hospital-and-life-science-stocks-strong-roadmap\/","title":{"rendered":"3 Hospital and Life Science Stocks With a Strong Future Roadmap: Park Medi World, Sai Life Sciences and Gujarat Kidney & Super Speciality"},"content":{"rendered":"

Park Medi World Rs 274.85, P\/E 39.89. Sai Life Rs 1,558.10, P\/E 91.42. Gujarat Kidney Rs 193.62, P\/E 91.23. Closing prices of 6 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Hospital and life science stocks with the clearest long-term roadmaps today include Park Medi World in multi-speciality hospitals in North India, Sai Life Sciences in drug discovery, development and manufacturing services for global pharma firms and Gujarat Kidney & Super Speciality in kidney care and super-speciality hospital services. FY26 revenue growth was 20.0% at Park Medi World, 29.5% at Sai Life and 105.2% at Gujarat Kidney. P\/E stands at 39.89 for Park Medi World (industry 62.73), 91.42 for Sai Life (industry 37.19) and 91.23 for Gujarat Kidney (industry 62.73). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Hospital and life science stocks give investors exposure to regional hospital chains and research services firms that serve patients and global drug makers. Results depend on bed occupancy, patient volumes and pharma customer orders, which is why capacity use matters as much as headline growth.<\/p>\n

This list covers three hospital and drug development stocks: Park Medi World for multi-speciality hospitals in North India, Sai Life Sciences for drug discovery, development and manufacturing services for global pharma firms and Gujarat Kidney & Super Speciality for kidney care and super-speciality hospital services. Every figure comes from the latest reported financials and the 6 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n